Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03384836
Title Propranolol Hydrochloride and Pembrolizumab in Treating Patients With Stage IIIC-IV Melanoma That Cannot Be Removed by Surgery
Recruitment Suspended
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Roswell Park Cancer Institute
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Emory University Hospital/ Winship Cancer Institute Atlanta Georgia 30322 United States Details
Roswell Park Cancer Institute Buffalo New York 14263 United States Details
Cleveland Clinic Cancer Center Cleveland Ohio 44195 United States Details
Penn State Milton S. Hershy Medical Center Cancer Institute Hershey Pennsylvania 17033 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field